A092730 logo

NeoPharm CO., LTD. Stock Price

KOSDAQ:A092730 Community·₩312.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A092730 Share Price Performance

₩19,990.00
8180.00 (69.26%)
₩19,990.00
8180.00 (69.26%)
Price ₩19,990.00

A092730 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet, undervalued and pays a dividend.

0 Risks
4 Rewards

NeoPharm CO., LTD. Key Details

₩129.8b

Revenue

₩43.9b

Cost of Revenue

₩85.9b

Gross Profit

₩58.1b

Other Expenses

₩27.8b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
1.78k
66.19%
21.41%
0%
View Full Analysis

About A092730

Founded
2000
Employees
178
CEO
Byeong-Deog Park
WebsiteView website
www.neopharm.co.kr

NeoPharm CO., LTD. engages in the manufacturing and sale of skin care products in South Korea. The company provides Atopalm, a non-steroid product for sensitive and dry skin; skin dermo-cosmetic products under the Real Barrier brand name; sensitive, dry, oily, or trouble-prone skin care products under the ZEROID brand; body moisturizers under the Derma-B brand name; sport care products under the MISSION ATHELETCARE brand; and dermArtlogy, a 1:1 consulting cosmetic brand. NeoPharm CO., LTD. was founded in 2000 and is headquartered in Daejeon, South Korea.

Recent A092730 News & Updates

NeoPharm (KOSDAQ:092730) Hasn't Managed To Accelerate Its Returns

Jan 22
NeoPharm (KOSDAQ:092730) Hasn't Managed To Accelerate Its Returns

Recent updates

No updates